In the Media
Are you looking for the latest media coverage of the BioMed X Institute, its research projects and people behind the innovation model? Here you will find the latest clippings – hot off the press!
Visit: Daiichi Sankyo gins up antibody research project with German research institute
Daiichi Sankyo gins up antibody research project with German research institute
Fierce Biotech
Visit: BioMed X Institute launched a new collaboration with Daiichi Sankyo in cancer therapy
BioMed X Institute launched a new collaboration with Daiichi Sankyo in cancer therapy
Medical Marketing + Media
Visit: BioMed X Institute launches new cancer collaboration with Daiichi Sankyo
BioMed X Institute launches new cancer collaboration with Daiichi Sankyo
bionity.com
Visit: BioMed X Institute joins forces with Daiichi Sankyo in cancer therapy
BioMed X Institute joins forces with Daiichi Sankyo in cancer therapy
The Pharma Letter
Visit: Heidelberger BioMed X kooperiert mit Daiichi
Heidelberger BioMed X kooperiert mit Daiichi
transkript
Visit: Germany’s BioMed X Institute launches new collaboration with Japanese firm Daiichi Sankyo in cancer therapy
Germany’s BioMed X Institute launches new collaboration with Japanese firm Daiichi Sankyo in cancer therapy
BioSpectrum Asia
Visit: BioMedX Launches Collaboration with Daiichi Sankyo to Explore New Approaches in Cancer Treatment
BioMedX Launches Collaboration with Daiichi Sankyo to Explore New Approaches in Cancer Treatment
Contract Pharma
Visit: BioMed X Institute Launches New Collaboration with Daiichi Sankyo in Cancer Therapy
BioMed X Institute Launches New Collaboration with Daiichi Sankyo in Cancer Therapy
PharmiWeb.com
Visit: Collaboration targets multi-specific biologics for solid tumour treatment
Collaboration targets multi-specific biologics for solid tumour treatment
Labmate Online
Visit: Daiichi Sankyo gins up antibody research project with German research institute
Daiichi Sankyo gins up antibody research project with German research institute
Fierce Biotech
Visit: Inside AION Labs, the AI-focused venture studio with the backing of AstraZeneca, Pfizer, AWS and other power players
Inside AION Labs, the AI-focused venture studio with the backing of AstraZeneca, Pfizer, AWS and other power players
R&D World